Tag: Strand Life Sciences
Uniparental Disomy: Shedding light on a rare genetic mystery
Dr Aparna Ganapathy, Director - Population Genomics, Strand Life Sciences explains how UPD diagnosis can provide a clear explanation for otherwise puzzling medical findings
Servier India partners MedGenome and Strand Life Sciences to advance biomarker...
The panel will be available to healthcare professionals across private and government sectors
Strand Life Sciences expands cutting edge sequencing facility
The new cutting-edge instruments will drive Strand's clinical genomic tests and the newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Reliance acquires majority stake in Strand Life Sciences for Rs. 393...
A further investment of up to Rs 160 crore is expected to be completed by March, 2023
Oncquest Lab acquires Quest Diagnostics Indian facilities from Strand
The acquisition adds a significant muscle power to Oncquest and will propel it into an aggressive growth trajectory. The erstwhile Quest diagnostic’s Gurugram facility was built with the best global standards in the year 2008 and is one of the largest Lab facilities in Asia...............
Fatigue panel test from Strand Life Sciences screens risk factors
An individual’s understanding of health risks is the key to make one’s healthcare decisions and the Fatigue Panel does just that............
Strand Life Sciences acquires India diagnostics business from Quest Diagnostics
The acquisition of Quest Diagnostics' assets is expected to boost the product portfolio of Strand Life Sciences helping it to strengthen and expand its base further...……….
Can conventional genetic tests be considered reliable?
The alarming number of genetic abnormalities in children is an indication that it is about time for us in India to embrace NGS routine genetic testing, as it is a comprehensive test (can detect all types of genetic mutations), accurate, fast, and cost-effective...........
Quadria Capital announces strategic investment into Strand Life Sciences
Investment is expected to help transform the Strand Life Sciences into Asia’s leading integrated specialised diagnostic and genomic research company.............
HCG’s Triesta business unit to merge with Strand Life Sciences
The combination of Triesta and Strand will create an integrated platform with the end to end capabilities in precision medicine........